相关实验视频

Updated: May 8, 2026

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances
08:18

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances

Published on: October 10, 2020

5.8K

对新型绿色合成纳米零价值的比较药理学研究

Fady Sayed Youssef1, Magdi E A Zaki2, Nadeen Nasser3

  • 1Pharmacology Department, Faculty of Veterinary Medicine, Cairo University 12211 Giza Egypt.

RSC advances
|July 4, 2025
PubMed
概括

绿色合成的纳米零价值 (GT-NZVAl) 显示出显著的抗氧化和抗炎性质. 这种环保的纳米粒子配方展示了具有良好的稳定性和低细胞毒性的潜在治疗应用.

更多相关视频

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

3.3K
Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres07:24

Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres

Published on: June 7, 2024

2.2K

相关概念视频

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...